Patents Assigned to Villya LLC
  • Praziquantel Formulations
    Publication number: 20220047506
    Abstract: Praziquantel may be formulated to enhance its pharmacokinetic, toxicity, and palatability properties. It can be stored and/or dispensed as a liquid, powder, or tablet. Reduction in the most common side effects improves patient compliance and satisfaction. Altered taste profile improves patient compliance and satisfaction. Once formulated it can be used to treat a variety of blood flukes and worms in human and veterinary subjects.
    Type: Application
    Filed: August 12, 2020
    Publication date: February 17, 2022
    Applicant: Villya LLC
    Inventor: William Miller
  • Treatment of Female Genital Schistosomiasis
    Publication number: 20210260062
    Abstract: Formulations of praziquantel are used to locally treat female genital schistosomiasis. The formulations can be applied to the upper or lower female genital tract, depending on the location of the infection. Thick or viscous formulations can be used advantageously in the vagina. Solutions of active ingredient can be instilled in the uterus.
    Type: Application
    Filed: December 2, 2020
    Publication date: August 26, 2021
    Applicant: Villya LLC
    Inventor: William Miller
  • Treatment of female genital schistosomiasis
    Patent number: 10857151
    Abstract: Formulations of praziquantel are used to locally treat female genital schistosomiasis. The formulations can be applied to the upper or lower female genital tract, depending on the location of the infection. Thick or viscous formulations can be used advantageously in the vagina. Solutions of active ingredient can be instilled in the uterus.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: December 8, 2020
    Assignee: Villya LLC
    Inventor: William Miller